TransCode Therapeutics In... (RNAZ)
NASDAQ: RNAZ
· Real-Time Price · USD
10.97
-0.08 (-0.72%)
At close: Aug 15, 2025, 3:59 PM
10.73
-2.19%
After-hours: Aug 15, 2025, 05:33 PM EDT
TransCode Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -12.09M | -5.92M | -2.32M | -5.19M | -3.33M | -4.09M | -5.3M | -4.34M | -4.82M | -5.13M | -4.29M | -4.67M | -3.47M | -2.8M | -2.33M | 2.77M | -4.49M |
Depreciation & Amortization | 51.17K | 122.86K | 127.52K | 142.83K | 141.65K | 140.17K | 138.78K | 137.59K | 100.2K | 29.5K | 24.8K | 22.7K | 21.6K | 28.99K | 7.54K | 4.69K | 1.25K |
Stock-Based Compensation | 157.73K | 168.77K | 204.48K | 1.14M | 183.15K | 310.31K | 392.33K | 175.48K | 158.76K | 130.56K | 105.6K | 98.6K | 60.57K | 39K | 64.05K | 34.51K | 48.43K |
Other Working Capital | -133K | 930.4K | -1.91M | 656.32K | -250.72K | 61.26K | -696.06K | 1.38M | -531.56K | 344.82K | -2.3K | 1.3M | 117.26K | 572.84K | -2.28M | 292.41K | -442.46K |
Other Non-Cash Items | 9.23M | 1.54M | n/a | 908.3K | 1.15M | 2.68M | -1.15M | 2.06M | -577.05K | 1.31B | 2.03K | 265.92K | 781.7K | 35.69K | -35.35K | 19.51K | 19.63K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -2.68M | 1.15M | -2.06M | 577.05K | -1.31B | n/a | -265.92K | n/a | 3.08K | 1.34K | -3.11M | 3.98M |
Change in Working Capital | -455K | 942.35K | -1.92M | 1.56M | -935.21K | -2.03M | 1.26M | -363.12K | 44.42K | 954.27K | -262.82K | 1.18M | -560.67K | 1.09M | -775.85K | 205.73K | -89.25K |
Operating Cash Flow | -3.1M | -3.15M | -3.91M | -2.34M | -3.94M | -5.66M | -3.51M | -4.39M | -4.51M | -4.02M | -4.42M | -3.37M | -3.95M | -1.6M | -3.07M | -76K | -522.15K |
Capital Expenditures | n/a | -500 | -12.87K | -4.55K | -3.84K | 35.61K | -4.61K | -18.11K | -12.9K | -28.21K | n/a | -42.05K | -30.66K | -85.73K | -71.55K | -22.24K | -75.3K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3K | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | -3.84K | -35.61M | n/a | n/a | -12.9M | -100.89M | n/a | n/a | -30.66M | 3K | n/a | n/a | n/a |
Investing Cash Flow | n/a | -500 | -12.87K | -4.55K | -3.84K | -35.57M | -4.61K | -18.11K | -12.9K | -28.21K | n/a | -42.05K | -30.66K | -82.73K | -71.55K | -22.24K | -75.3K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 135.8K | -135.8K | n/a | 225.82K | -225.82K | 5.98K | 5.99K | 9.48K | 25.56M | 78.84K | -131.6K |
Financial Cash Flow | 8.86M | 7.08M | 2.45M | 785.2K | 6.09M | 978.15K | 7.39M | 6.36M | 1.18M | 225.82K | -225.82K | 5.98K | 5.99K | 9.48K | 25.56M | 78.84K | -131.6K |
Net Cash Flow | 5.76M | 3.94M | -1.48M | -1.56M | 2.15M | -4.69M | 3.88M | 1.95M | -3.35M | -3.82M | -4.65M | -3.41M | -3.97M | -1.67M | 22.42M | -19.39K | -729.05K |
Free Cash Flow | -3.1M | -3.15M | -3.93M | -2.34M | -3.94M | -5.63M | -3.51M | -4.41M | -4.53M | -4.05M | -4.42M | -3.41M | -3.98M | -1.69M | -3.14M | -98.24K | -597.45K |